GEODE CAPITAL MANAGEMENT, LLC
Position in WHWK — Whitehawk Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in WHWK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,578,513
+$548,949 QoQ
Shares Held
457,540
+7.5% QoQ
Ownership
0.925%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WHWK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. WHWK ranks #289 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in WHWK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,578,513 | 457,540 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,029,564 | 425,440 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $725,331 | 381,754 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $696,263 | 372,334 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $419,795 | 235,840 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $685,562 | 217,294 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $430,020 | 208,748 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $301,406 | 206,443 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $934,200 | 399,231 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $799,631 | 395,857 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,775,205 | 366,778 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,274,388 | 332,513 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,967,100 | 271,699 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,349,733 | 261,086 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,623,002 | 256,405 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,840,353 | 311,717 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,346,212 | 197,184 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,759,312 | 197,073 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $825,385 | 28,103 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||